Home » Topics » BioWorld Science

BioWorld Science
RSS

Depression's doldrums linked to diagnostic duality at ECNP

Oct. 5, 2021

New model provides insight into tau propagation in early Alzheimer's disease

Oct. 5, 2021

Taysha collaborates with UTSW on next-generation construct for the treatment of CLN7 disease

Oct. 5, 2021

KRP-A218, an oral PI4KB inhibitor, is a potent antiviral in vivo

Oct. 5, 2021

Protein mimetic amyloid inhibitor shows antitumor activity in vivo

Oct. 5, 2021

Targeting ADGRF1 for obesity and associated metabolic diseases

Oct. 5, 2021

OncoTherapy Science presents data on OTSA-101 in cervical cancer mouse model

Oct. 5, 2021

Selecta and Takeda enter strategic licensing agreement for lysosomal storage disorders

Oct. 5, 2021

JSF-3151 demonstrates efficacy in mouse model of MRSA infection

Oct. 5, 2021

Microbiome therapy SER-155 may restore colonization resistance and prevent infection

Oct. 5, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...